XML 16 R6.htm IDEA: XBRL DOCUMENT v3.25.2
Consolidated Statements of Shareholders' Equity - USD ($)
$ in Thousands
Total
Common stock
Common stock
Retained earnings
Accumulated other comprehensive income (loss)
Common stock shares outstanding, beginning balance (in shares) at Dec. 31, 2023   18,810,055      
Beginning balance at Dec. 31, 2023 $ 538,387   $ 229,889 $ 395,357 $ (86,859)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) (13,735)     (13,735)  
Share-based compensation expense 1,966   1,966    
Common stock issued - Stock grants (in shares)   60,483      
Common stock issued - Stock grants 0        
Other comprehensive income (loss) (6,367)       (6,367)
Common stock repurchased (in shares)   (12,973)      
Common stock repurchased (134)   (134)    
Common stock shares outstanding, ending balance (in shares) at Jun. 30, 2024   18,857,565      
Ending balance at Jun. 30, 2024 520,117   231,721 381,622 (93,226)
Common stock shares outstanding, beginning balance (in shares) at Mar. 31, 2024   18,857,565      
Beginning balance at Mar. 31, 2024 527,333   230,814 387,860 (91,341)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) (6,238)     (6,238)  
Share-based compensation expense 907   907    
Other comprehensive income (loss) (1,885)       (1,885)
Common stock shares outstanding, ending balance (in shares) at Jun. 30, 2024   18,857,565      
Ending balance at Jun. 30, 2024 $ 520,117   231,721 381,622 (93,226)
Common stock shares outstanding, beginning balance (in shares) at Dec. 31, 2024 18,857,565 18,857,565      
Beginning balance at Dec. 31, 2024 $ 396,997   233,185 251,013 (87,201)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) (8,877)     (8,877)  
Share-based compensation expense 1,200   1,200    
Common stock issued - Stock grants (in shares)   94,688      
Common stock issued - Stock grants 0        
Other comprehensive income (loss) 14,020       14,020
Common stock repurchased (in shares)   (31,445)      
Common stock repurchased $ (359)   (359)    
Common stock shares outstanding, ending balance (in shares) at Jun. 30, 2025 18,920,808 18,920,808      
Ending balance at Jun. 30, 2025 $ 402,981   234,026 242,136 (73,181)
Common stock shares outstanding, beginning balance (in shares) at Mar. 31, 2025   18,920,808      
Beginning balance at Mar. 31, 2025 400,751   233,418 246,548 (79,215)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) (4,412)     (4,412)  
Share-based compensation expense 608   608    
Other comprehensive income (loss) $ 6,034       6,034
Common stock shares outstanding, ending balance (in shares) at Jun. 30, 2025 18,920,808 18,920,808      
Ending balance at Jun. 30, 2025 $ 402,981   $ 234,026 $ 242,136 $ (73,181)